Last week MVA-member, Symbion, celebrated the official Grand Opening of the latest addition to the Symbion Community: The new location ‘Symbion Frederiksberg‘, which will be the future home to start-up companies withing life science and greentech! (Tennants such as Minervax, Hemab and Acesion Pharma have already moved in)
Symbion Frederiksberg is located in newly renovated iconic former Novo Nordisk building literally on the border between Frederiksberg and Copenhagen, and as such there is an element of the circle of life within life science to the venue, which will now also be a nest for future life science innovation. The Grand Opening with several hundred guest included speeches from former CEO of Novo Nordisk Mads Øvlisen, Frederiksberg’s Mayor Michael Vindfeldt, Chairman of the Board of Symbion Jørgen Bardenfleth and CEO of Symbion Peter Torstensen.